Medtronic Says Stent Successfully Treats Long Lesions and Small Vessels

For the treatment of long lesions and small vessels -- two challenging characteristics of coronary artery disease commonly found in patients with diabetes -- the Resolute drug-eluting stent from Medtronic, Inc.

delivered successful clinical results, according to new data presented at the 24^th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. "The Resolute stent continues to provide consistent and favorable clinical results," said Ronald Caputo, M.D., director of cardiac services and cardiology research at St. Joseph's Hospital in Syracuse, N.Y. "Patients with long lesions and small vessels are among the most difficult to treat, and for those who also have diabetes it can be even more challenging."